Morrison Foerster’s FDA + Healthcare Regulatory and Compliance Group Recognized by Chambers USA 2024 and The Legal 500 2024

Morrison Foerster’s FDA + Healthcare Regulatory and Compliance practice has been highlighted by both Chambers USA and The Legal 500 in their 2024 editions. Chambers USA named Morrison Foerster as a top practice in its District of Columbia: Healthcare: Pharmaceutical/Medical Products Regulatory category, while The Legal 500 also recognized the firm as leader in the Nationwide: Healthcare: Life Sciences ranking. These rankings serve as a testament to MoFo’s burgeoning FDA + Healthcare practice, which is now recognized among the best in the nation.

Stacy Cline Amin, who serves as head of MoFo’s FDA + Healthcare Regulatory and Compliance Group, was elevated by Chambers USA to Band 3 of the District of Columbia: Healthcare: Pharmaceutical/Medical Products Regulatory ranking. Stacy’s dedicated practice has seen her named to this ranking table for the third consecutive year, with one client stating, “she is truly one of a kind in terms of her experience, approach and judgment. We have found her extraordinarily helpful as we navigate complexities.”

Brigid Bondoc was also named by Chambers in Band 5 for the District of Columbia: Healthcare: Pharmaceutical/Medical Products Regulatory category. She is recognized among her colleagues and clients as a go-to lawyer for complex and highly nuanced issues before the FDA. A client commented, “Brigid is a very strong lawyer; she is pragmatic and thoughtful.”

MoFo’s FDA + Healthcare Regulatory and Compliance practice is unique in the industry for being a small group that is sought after by the world’s leading innovators for their strategic thinking and pragmatic approach. While many firms are well known for one or two practice areas in the healthcare and life sciences industries, MoFo counsels clients through every phase of the growth cycle across all life sciences product areas. The growing practice in Washington, D.C. provides strategic counsel to healthcare and life sciences clients as they navigate their most complex and challenging, and often novel, regulatory, compliance, and marketplace issues. Morrison Foerster is a go-to practice for companies navigating regulatory issues of first impression.

We congratulate the entire FDA + Healthcare Regulatory and Compliance practice at Morrison Foerster on their continued growth and success.

Chambers USA and The Legal 500 are annual publications highlighting market-leading firms and lawyers based on extensive research and in-depth interviews with clients and peers. To view the complete list of Morrison Foerster’s rankings in the 2024 editions, please visit the publication’s websites at the following links: Chambers USA and The Legal 500.